European Site Corporate Site Contact Us

Fact Sheet

Back to News and Events

HutchinsonTechnology Incorporated

Hutchinson Technology Incorporated is a global technology leader committed to developing innovative product solutions for critical customer problems. The company’s culture of quality excellence, continuous improvement, superior innovation and a relentless focus on the fundamentals have enabled it to lead in the markets it serves.
Hutchinson Technology was founded in 1965 by two young entrepreneurs who met by coincidence when living in the same apartment building in Minneapolis, Minnesota. Jon Geiss, a native of Hutchinson, Minnesota, was working as an engineer at Minnco Products, while Jeff Green was a contract technical writer for Sperry Univac. They financed the company with $30,000 and started a photoetching business in a former chicken coop in Hutchinson. Their first product was a printed circuit board for Univac.
Since those early days, Hutchinson Technology has grown from a start-up operation housed in a chicken coop to a global company with more than 5,500 employees.  

Suspension Assemblies for Disk Drives – The Company’s Foundation
Hutchinson Technology’s primary products are suspension assemblies for disk drives. Suspension assemblies are precise electro-mechanical components that hold a disk drive's recording head at microscopic distances above the drive's disks. The company’s Disk Drive Components Division is the world’s leading supplier of suspension assemblies for all sizes of disk drives produced by all the major disk drive makers.

Suspension assemblies are the product of sophisticated engineering design and process development. Continual advances in disk drive technology require suspension assemblies with expanded functionality and greater precision. Through close collaboration with its customers, Hutchinson Technology develops innovative product features that meet ever-increasing disk drive performance requirements.

Hutchinson Technology’s advanced suspension designs continue to enable the combination of rising disk drive capacity and declining prices, which has fueled the demand for data storage and created new opportunities for disk drives in consumer electronics devices.

Health Care
Hutchinson Technology’s BioMeasurement Division was established to leverage the company’s culture of quality, engineering capabilities and leading-edge measurement technology in the medical market. As a company with a long tradition of developing innovative solutions to customers’ problems, Hutchinson Technology’s venture into the medical market started by gaining an understanding what customers value. Through discussions and focus groups with clinicians across the country, a common problem facing clinicians was identified: the need to measure tissue oxygenation in specific regions of the body.

The company found there was no technology available capable of providing this important piece of information. Others before had measured whether oxygen levels were going up or down, but had not been able to solve the technical challenges associated with providing a quantitative value. In response, Hutchinson Technology applied its engineering capabilities and leading-edge measurement technology to develop its first medical product, a research device that measured local tissue oxygenation (StO2) directly, noninvasively and continuously. The device received FDA clearance in 2002.

To ensure the technology would address real and unanswered medical needs, the company established a Trauma Advisory Board of leading surgeons in 2003 and has worked with researchers to demonstrate the potential clinical utility and economic value of measuring StO2.

Long term, Hutchinson Technology’s BioMeasurement Division is committed to its vision of Advancing Better Therapies by applying its engineering and manufacturing expertise to address significant technological needs within the clinical health care community.

The InSpectra™ StO2 Tissue Oxygenation Monitor
In July, 2006, Hutchinson Technology received FDA clearance to begin marketing its second-generation InSpectra StO2 Tissue Oxygenation Monitor. This patented device uses near infrared technology to provide a direct measurement of StO2. For the first time, trauma teams have a continuous, noninvasive way to measure tissue oxygenation and monitor it during resuscitation. The InSpectra StO2 System is the only tissue oxygenation monitor designed for trauma environments. Trauma teams will appreciate that it is:
  • Noninvasive. The adhesive-backed InSpectra StO2 Sensor attaches easily to the patient’s thenar eminence.

  • Quick. The InSpectra StO2 System provides readings 20 seconds after start-up. No calibration needed.

  • Continuous. The InSpectra StO2 Monitor provides a continuous numeric reading and a trended display.

  • Portable. Rugged battery-operated monitor moves with the patient, and the sensor can be re-connected to other InSpectra StO2 Monitors throughout the hospital.

The technology platforms used to develop Hutchinson Technology’s medical device products include optical metrology, and specifically, near infrared spectroscopy. Coupled with HTI's world leadership in precision engineering, these technologies provide a powerful foundation for continued innovation in health care.

Hutchinson Technology’s BioMeasurement Division has two locations:

United States:
Hutchinson Technology Inc.
BioMeasurement Division
40 West Highland Park Drive NE
Hutchinson, MN 55350-9784
tel: 800.419.1007
tel: 320.587.1926
fax: 320.587.1555
Hutchinson Technology Inc.
European Business Office
IJsselburcht 3
6825 BS Arnhem
The Netherlands
tel: +31 26 365 3371
fax: +31 26 365 3372

Indications for Use for the InSpectra StO2 Tissue Oxygenation Monitor
The InSpectra StO2 Tissue Oxygenation Monitor is a noninvasive monitoring system that measures an approximated value of percent hemoglobin oxygen saturation in tissue (StO2). The InSpectra StO2 Tissue Oxygenation Monitor is indicated for use in monitoring patients during circulatory or perfusion examinations of skeletal muscle, or when there is a suspicion of compromised circulation.

The InSpectra™ StO2 Tissue Oxygenation Monitor provides a direct, absolute measurement of hemoglobin oxygen saturation in tissue (StO2), providing trauma teams the ability to measure tissue oxygenation and monitor it during resuscitation. It is the only tissue oxygenation monitor designed for trauma environments. The InSpectra StO2 Tissue Oxygenation Monitor uses near infrared light to illuminate tissue, and then analyzes the returned light to produce a quantitative measurement of oxygen saturation in the tissue's microcirculation.

The StO2 Trauma Study researched the role that tissue oxygen saturation monitoring could play in hemorrhagic shock and resuscitation. Study results demonstrate that StO2 measurements less than 75% may indicate serious hypoperfusion in trauma patients and that StO2 functions as well as base deficit in indicating hypoperfusion in trauma patients.